In prostate cancer, researchers found that lncRNA SNHG3, lncRNA prostate cancer-associated transcript 1 (PCAT1) and lncRNA OIP5-AS1 could affect SLC7A11 mRNA expression through different regulatory mechanisms. This evidence concerns the gene SLC7A11 and prostate carcinoma.